These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 28237418)
1. MicroRNAs in Lung Development and Disease. Ameis D; Khoshgoo N; Iwasiow BM; Snarr P; Keijzer R Paediatr Respir Rev; 2017 Mar; 22():38-43. PubMed ID: 28237418 [TBL] [Abstract][Full Text] [Related]
2. MicroRNAs in lung diseases: Recent findings and their pathophysiological implications. Ebrahimi A; Sadroddiny E Pulm Pharmacol Ther; 2015 Oct; 34():55-63. PubMed ID: 26319446 [TBL] [Abstract][Full Text] [Related]
3. New insights into lung development and diseases: the role of microRNAs. Johar D; Siragam V; Mahood TH; Keijzer R Biochem Cell Biol; 2015 Apr; 93(2):139-48. PubMed ID: 25563747 [TBL] [Abstract][Full Text] [Related]
4. Role of MicroRNAs in lung disease. Angulo M; Lecuona E; Sznajder JI Arch Bronconeumol; 2012 Sep; 48(9):325-30. PubMed ID: 22607962 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression profiles and target prediction in neonatal Wistar rat lungs during the development of bronchopulmonary dysplasia. Xing Y; Fu J; Yang H; Yao L; Qiao L; Du Y; Xue X Int J Mol Med; 2015 Nov; 36(5):1253-63. PubMed ID: 26398774 [TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in lung diseases. Pagdin T; Lavender P Thorax; 2012 Feb; 67(2):183-4. PubMed ID: 21836155 [TBL] [Abstract][Full Text] [Related]
8. miRNAs in Lung Development and Diseases. Boateng E; Krauss-Etschmann S Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316149 [TBL] [Abstract][Full Text] [Related]
9. Expression profile of microRNAs in fetal lung development of Sprague-Dawley rats. Yang Y; Kai G; Pu XD; Qing K; Guo XR; Zhou XY Int J Mol Med; 2012 Mar; 29(3):393-402. PubMed ID: 22160159 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression profile in hyperoxia-exposed newborn mice during the development of bronchopulmonary dysplasia. Zhang X; Peng W; Zhang S; Wang C; He X; Zhang Z; Zhu L; Wang Y; Feng Z Respir Care; 2011 Jul; 56(7):1009-15. PubMed ID: 21310116 [TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis, pediatrics, control of breathing, pulmonary physiology and anatomy, and surfactant biology in AJRCCM in 2004. Bush A; Accurso F; Macnee W; Lazarus SC; Abraham E Am J Respir Crit Care Med; 2005 Mar; 171(6):545-53. PubMed ID: 15753484 [No Abstract] [Full Text] [Related]
12. Therapeutic modulation of miRNA for the treatment of proinflammatory lung diseases. Hassan T; McKiernan PJ; McElvaney NG; Cryan SA; Greene CM Expert Rev Anti Infect Ther; 2012 Mar; 10(3):359-68. PubMed ID: 22397568 [TBL] [Abstract][Full Text] [Related]
13. MicroRNAs: potentially important regulators for schistosome development and therapeutic targets against schistosomiasis. Cheng G; Jin Y Parasitology; 2012 Apr; 139(5):669-79. PubMed ID: 22309492 [TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in development and disease. Erson AE; Petty EM Clin Genet; 2008 Oct; 74(4):296-306. PubMed ID: 18713256 [TBL] [Abstract][Full Text] [Related]
16. Corticosteroids in respiratory diseases in children. de Benedictis FM; Bush A Am J Respir Crit Care Med; 2012 Jan; 185(1):12-23. PubMed ID: 21920920 [TBL] [Abstract][Full Text] [Related]
17. The role of inflammation in airway disease: remodeling. Tiddens H; Silverman M; Bush A Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 2):S7-S10. PubMed ID: 10934123 [No Abstract] [Full Text] [Related]
18. The roles of miRNAs as potential biomarkers in lung diseases. Alipoor SD; Adcock IM; Garssen J; Mortaz E; Varahram M; Mirsaeidi M; Velayati A Eur J Pharmacol; 2016 Nov; 791():395-404. PubMed ID: 27634639 [TBL] [Abstract][Full Text] [Related]